https://resources.ajpeptide.com/ Know Your Vial: plain-English peptide chemistry, testing standards and clinical evidence from AJ Peptide. en-us Fri, 23 Oct 2026 15:00:00 +0000 https://resources.ajpeptide.com/cjc-1295-ipamorelin.html https://resources.ajpeptide.com/cjc-1295-ipamorelin.html Fri, 23 Oct 2026 15:00:00 +0000 Built for solution stability, two receptor pathways, a stronger GH pulse and a longer half-life than sermorelin. A peptide chemist makes the CMC case against sermorelin and tesamorelin, residue by residue, and shows where the evidence stops. https://resources.ajpeptide.com/nad-injections-vs-iv-vs-supplements.html https://resources.ajpeptide.com/nad-injections-vs-iv-vs-supplements.html Wed, 21 Oct 2026 15:00:00 +0000 Three ways to take NAD+, three very different products. What each route delivers, what the human evidence actually shows, and five quality questions to ask before you start, because NAD+ is a fragile molecule. https://resources.ajpeptide.com/503a-vs-research-grade-peptides.html https://resources.ajpeptide.com/503a-vs-research-grade-peptides.html Tue, 20 Oct 2026 15:00:00 +0000 Same name on the label, different material in the vial. What the law requires of a pharmacy’s peptide, the GMP specification it’s released on, and how the finished vial is tested, compared step by step with a research-grade vial. https://resources.ajpeptide.com/retatrutide-trials-vs-gray-market.html https://resources.ajpeptide.com/retatrutide-trials-vs-gray-market.html Mon, 19 Oct 2026 15:00:00 +0000 In Lilly’s trials, the top side effect was nausea. Among gray-market users on Reddit, it was hunger. A peptide chemist compares the trial data with what people injecting “research use only” vials report, and explains why the vial matters as much as the molecule. https://resources.ajpeptide.com/hplc-purity-explained.html https://resources.ajpeptide.com/hplc-purity-explained.html Sun, 11 Oct 2026 15:00:00 +0000 Two vials can both read 99.1% pure. A peptide chemist explains what HPLC purity measures, how a fast method hides impurities under the main peak, and what to ask for instead. https://resources.ajpeptide.com/tirzepatide-not-just-for-weight-loss.html https://resources.ajpeptide.com/tirzepatide-not-just-for-weight-loss.html Fri, 09 Oct 2026 15:00:00 +0000 Four FDA approvals and what the large trials found for blood pressure, the heart, sleep apnea, the liver and diabetes prevention — plus what happened when tirzepatide and semaglutide were tested head to head. https://resources.ajpeptide.com/semaglutide-beyond-the-scale.html https://resources.ajpeptide.com/semaglutide-beyond-the-scale.html Fri, 09 Oct 2026 15:00:00 +0000 What the large randomized trials found for the heart, kidneys, liver and joints — the actual numbers, which doses and patients were studied, and what the results don’t tell you. https://resources.ajpeptide.com/route-of-administration.html https://resources.ajpeptide.com/route-of-administration.html Fri, 09 Oct 2026 15:00:00 +0000 Most therapeutic peptides reach about 1–2% oral bioavailability at best. What happens to a peptide you swallow, what it took to make oral semaglutide work, and why route of administration should follow the evidence. https://resources.ajpeptide.com/sermorelin-vs-tesamorelin.html https://resources.ajpeptide.com/sermorelin-vs-tesamorelin.html Fri, 09 Oct 2026 15:00:00 +0000 Both peptides tell your pituitary to make its own growth hormone. A peptide chemist explains how they differ in structure, clinical evidence, and how hard they are to manufacture well. https://resources.ajpeptide.com/coa-comparison.html https://resources.ajpeptide.com/coa-comparison.html Fri, 09 Oct 2026 15:00:00 +0000 Why products labeled “research use only” are not made, tested, or dispensed for human use — and what a licensed 503A pharmacy does differently. Read the article → Article What's Actually in Your Vial — And How to Tell A side-by-side comparison of grey-market, research-market, and GMP/pharmacy-release documentation — what's tested at each tier, and why purity alone isn't a safety profile.